Atara Biotherapeutics (ATRA) BidaskScore is downgraded to Sold

Atara Biotherapeutics

The BidaskScore of Atara Biotherapeutics ATRAATRA shows that the shares of the company are now ATRAStrongly Bought Sold by investors.

The BidaskScore of the BiotechnologyBiotechnology shows that the sector is BiotechnologyStrongly Bought Sold since March 26.

Here are the BidAskScore of other related companies in the Biotechnology sector:

Atara Biotherapeuticsˌ Inc. operates as a clinical stage biopharmaceutical company which focuses on developing novel therapeutics for serious unmet medical needsˌ with an initial focus on muscle wasting conditions and oncology. Its product candidates are biologics targeting myostatin and activinˌ members of the transforming growth factor-betaˌ protein superfamilyˌ which play roles in the growth and maintenance of muscle and many other body tissues. The company was founded by Isaac E. Ciechanover on August 22ˌ 2012 and is headquartered in South San Franciscoˌ CA.

Atara Biotherapeutics

Launched in 2016, the BidAskClubBidaskClub allows users to follow the evolution of the US equity market. BidaskClub provides a platform to create portfolios and be informed when a company´s or sector’s BidaskScore changes. BidaskClub is provided by LuxFinAdviceLuxFinAdvice.